RE:RE:Any thoughts?Considering the guidance Thera gave us for the trial restart date and the statement "quickly enroll patients" I feel an update/explanation is overdue...Maybe addresing this is one of the reasons for their early Q3 date.
SPCEO1 wrote: My cousin had to be off her old chemo for a month before she could start on he earlier trial. With testing and other stuff needed to get done, it may have been almost 6 weeks between when she decided to move forward and when she was first dosed.
Also, being off chemo for that long isn't helpful at this stage of the diease. That is a disincentive for still somewhat healthy patients to join a new trial.
And there are competing options out there. Having paused the previous trial, an average somewhat healthier patient may opt for a new drug option without any black marks on it. The cost of getting healthier patients may be greater difficulty in convincing them to join your trial.
Wino115 wrote: Why has it taken longer than it should to find Patient #1 for the P1 trial?
Which of these reasons is right or wrong?
Criteria making it hard? (To me, not that different than most trials.)
No incentive from Drs as clinic payments may be lowered?
Biopsy lengthen's time - I don't think they're doing the Sort1 staining, but could be wrong?
Patients picking other similar target-drug trials so being crowded out given past results and small size?